Atrial Fibrillation (AF), Heart Failure, Myocardial Infarction (MI), Pacemaker Implantation
Conditions
Keywords
Augmented reality, Acute Coronary Syndrome, Heart Failure, Pacemaker, PREM, Atrial Fibrillation
Brief summary
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. This study includes adult patients who are admitted to a cardiology department because of: * Ischaemic heart disease * Atrial fibrillation * Heart failure * Or who need a pacemaker implantation The main questions this study aims to answer are: * Does providing augmented reality information at discharge improve patients' perceived quality of care? * Does it improve patients' adherence to their prescribed treatment? * Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death? Researchers will compare two groups of participants: * A control group, who will receive the usual medical discharge report. * An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application. Participants will: * Receive their discharge information according to the group they are assigned to. * Use the augmented reality application if they are in the intervention group. * Be followed over time to assess treatment adherence, patient experience, and cardiovascular events. This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
Interventions
DEVICEAugmented reality app
The card provided in addition to the usual medical discharge report is designed with a simple drawing that identifies each condition and a QR code. This code can be scanned from any mobile device using the device's camera. Once scanned, a 3D model of a heart or a stent (depending on the condition) appears on the device, showing movement, vibration, and sound as an example of augmented reality. The user can also access simple options through three buttons: 1. Video recorded by a cardiology professional: a brief and easy-to-understand explanation of the patient's condition, lasting approximately 2-3 minutes, provided by a hospital cardiology professional. 2. Treatment recommendations: a drop-down section with a table of discharge recommendations for the patient's condition, including lifestyle and dietary advice. 3. Warning signs: situations that the patient should pay attention to and seek medical advice if they occur.
Sponsors
Hospital Universitario Getafe
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participants must have access to a mobile device (such as a smartphone or tablet). * Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.
Exclusion criteria
* No access to a mobile device. * Untreated visual or hearing impairments that prevent viewing or understanding the videos. * Inability to understand Spanish
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PRIMARY OUTCOME: PREM and treatment adherence at one and six months | Follow up at one and six months from enrollment | To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| MACE at one and six months | From enrollment at one and six months | Data on major adverse cardiovascular events (MACE) will also be collected at one and six months from discharge in both groups. MACE include heart attack, stroke, cardiovascular-related hospital readmission, and cardiovascular death. |
Countries
Spain
Outcome results
None listed